Igenomixpart Of The Vitrolife Groupis A Prominent Provider Of Reproductive Genetic Testing Servicesprimarily For Ivf Clinicsheadquartered In Valenciaspainthe Company Employs Around 501 1000 People And Operates Within The Biotechnology Research Sectorsince Its Acquisition By Vitrolife In 2021Igenomix Has Enhanced Its Offerings By Integrating Its Genetic Testing Expertise With Vitrolife S Medical Devices And Solutions For Reproductive Health Igenomix Specializes In Advanced Genetic Assessments That Support Ivf Treatmentshelping To Improve Outcomes For Patientsthe Company Serves Ivf Clinics Globallyproviding Essential Services That Leverage Cutting Edge Genetic Testing Technologieswith A Presence In Over 125 Countries And Direct Operations In More Than 25Igenomix Is Dedicated To Enhancing Reproductive Health Care Through Innovation And Quality
